Medtronic Revo MRI Pacer Approved, But Still Faces Reimbursement Hurdle
This article was originally published in The Gray Sheet
Executive Summary
Medtronic is hoping that the immediate U.S. launch of its newly approved Revo MRI SureScan MRI-compatible pacemaker will help boost market share in the device category, but magnetic resonance imaging scans of implant recipients still face a key reimbursement hurdle.